Intravenous immunoglobulins for treatment of severe COVID-19-related acute encephalopathy

J Neurol. 2022 Aug;269(8):4013-4020. doi: 10.1007/s00415-022-11152-5. Epub 2022 May 10.

Shufan Huo^#^{1

2

3}, Caroline Ferse^#⁴, Fabian Bösl⁵, S Momsen Reincke^{5

6}, Philipp Enghard⁴, Carl Hinrichs⁴, Sascha Treskatsch⁷, Stefan Angermair⁷, Kai-Uwe Eckardt⁴, Heinrich J Audebert^{5

8}, Christoph J Ploner^{5

9}, Matthias Endres^{5

8

10

6

9}, Harald Prüss^{5

6}, Christiana Franke⁵, Franziska Scheibe^#^{5

11}

¹ Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany. [email protected].
² Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany. [email protected].
³ DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany. [email protected].
⁴ Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
⁵ Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.
⁶ German Center for Neurodegenerative Diseases (DZNE), Berlin, Germany.
⁷ Department of Anesthesiology and Intensive Care Medicine, Charité-Universitätsmedizin Berlin, Freie Universität and Humboldt-Universität zu Berlin, Berlin, Germany.
⁸ Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
⁹ Berlin Institute of Health at Charité-Universitätsmedizin Berlin, Berlin, Germany.
¹⁰ DZHK (German Centre for Cardiovascular Research), partner site Berlin, Berlin, Germany.
¹¹ NeuroCure Cluster of Excellence, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt Universität zu Berlin, Berlin, Germany.

^# Contributed equally.

No abstract available

Publication types